Last updated: Oct 30, 2026, 12:00 AM

CytomX Therapeutics Inc Exchange (NASDAQ, USD)

CTMX

2.34
-0.07 (-2.97%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-31.02%
3 year return (CAGR)
21.71%
5 year return (CAGR)
-14.83%
10 year return (CAGR)
-15.78%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
498.99M
Price/Sales
27.26
Ent value
560.92M
Price/Book
1.65
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-3.63%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-29.30%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open2.38
Daily high2.41
Daily low2.25
Daily Volume4.63M
All-time high34.22
1y analyst estimate12.25
Beta2.14
EPS (TTM)-0.36
Dividend per share0.00
Ex-div date-
Next earnings date4 Mar 2026

Ready to capitalize on CytomX Therapeutics Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
CTMXS&P500
Current price drop from All-time high-93.16%-3.00%
Highest price drop-98.74%-56.47%
Date of highest drop7 Apr 20259 Mar 2009
Avg drop from high-71.39%-10.65%
Avg time to new high79 days12 days
Max time to new high2172 days1805 days